- Investing Ideas
- /
- Global Large Cap High Growth Potential
Global Large Cap High Growth Potential
Results
631
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
631 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
600760 | CN¥47.58 | -4.9% | 11.9% | CN¥131.1b | CN¥53.90 | PE53.3x | E29.3% | 0.8% | Capital Goods | ||
9992 | HK$86.55 | 13.4% | 257.6% | HK$114.8b | HK$80.40 | PE69.9x | E35.4% | 0.3% | Retail | ||
RHM | €617.80 | 2.1% | 125.4% | €26.8b | €688.93 | PE39.2x | E29.0% | 0.9% | Capital Goods | ||
ARES | US$178.83 | 5.0% | 63.0% | US$35.5b | US$174.38 | PE83.5x | E46.3% | 2.1% | Diversified Financials | ||
SRPT | US$130.50 | 22.4% | 58.0% | US$11.0b | US$184.78 | PE102.3x | E42.9% | n/a | Pharmaceuticals & Biotech | ||
ONON | US$57.98 | 8.6% | 101.4% | US$18.7b | US$58.68 | PE130.7x | E29.6% | n/a | Consumer Durables | ||
ALNY | US$253.35 | 8.1% | 57.0% | US$32.4b | US$301.21 | PS15.6x | E70.7% | n/a | Pharmaceuticals & Biotech | ||
NVDA | US$136.86 | -6.9% | 186.2% | US$3.3t | US$170.44 | PE53.1x | E24.7% | 0.03% | Semiconductors | ||
SUZLON | ₹63.57 | 2.2% | 63.2% | ₹867.6b | ₹74.83 | PE90.4x | E39.4% | n/a | Capital Goods | ||
300308 | CN¥127.04 | -5.8% | 87.7% | CN¥140.3b | CN¥191.56 | PE30.3x | E32.6% | 0.3% | Tech | ||
CGPOWER | ₹735.45 | 2.4% | 70.4% | ₹1.1t | ₹752.40 | PE126x | E23.4% | 0.2% | Capital Goods | ||
511243 | ₹1,264.65 | 2.4% | 14.3% | ₹1.1t | ₹1,528.00 | PE27.6x | E21.9% | 0.2% | Diversified Financials | ||
NU | US$13.94 | 3.6% | 72.1% | US$68.4b | US$15.92 | PB8.8x | E29.0% | n/a | Banks | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
300502 | CN¥115.46 | -7.6% | 157.4% | CN¥81.8b | CN¥151.97 | PE43x | E36.7% | 0.1% | Tech | ||
A196170 | ₩297,000.00 | -21.0% | 275.9% | ₩15.8t | ₩476,666.67 | PS212.8x | E130.7% | n/a | Pharmaceuticals & Biotech | ||
BX | US$191.66 | 3.7% | 78.1% | US$148.3b | US$169.65 | PE66.2x | E27.9% | 1.7% | Diversified Financials | ||
FM | CA$18.69 | 1.7% | 47.9% | CA$15.6b | CA$21.38 | PS2.3x | E71.2% | n/a | Materials | ||
600989 | CN¥16.38 | 1.0% | 10.3% | CN¥120.1b | CN¥21.74 | PE19.1x | E38.8% | 1.7% | Materials | ||
SOLARINDS | ₹10,233.30 | 2.5% | 53.5% | ₹926.0b | ₹11,698.00 | PE91.6x | E27.0% | 0.08% | Materials | ||
ARGX | €576.60 | 8.3% | 41.2% | €34.8b | €578.70 | PS19.1x | E55.4% | n/a | Pharmaceuticals & Biotech | ||
KSPI | US$109.62 | -0.2% | 14.2% | US$20.2b | US$139.13 | PE10.7x | E23.7% | 6.2% | Diversified Financials | ||
SMCI | US$34.42 | 21.7% | 20.5% | US$22.5b | US$40.32 | PE16.7x | E24.3% | n/a | Tech | ||
BAJFINANCE | ₹6,617.95 | 0.3% | -7.1% | ₹4.1t | ₹8,034.57 | PE26.6x | E22.9% | 0.5% | Diversified Financials |